0001567619-21-014770.txt : 20210809 0001567619-21-014770.hdr.sgml : 20210809 20210809170136 ACCESSION NUMBER: 0001567619-21-014770 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210805 FILED AS OF DATE: 20210809 DATE AS OF CHANGE: 20210809 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STONEPINE CAPITAL, L.P. CENTRAL INDEX KEY: 0001370042 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37500 FILM NUMBER: 211157318 BUSINESS ADDRESS: STREET 1: 919 NW BOND STREET STREET 2: SUITE 204 CITY: BEND STATE: OR ZIP: 97703 BUSINESS PHONE: 541-647-5664 MAIL ADDRESS: STREET 1: 919 NW BOND STREET STREET 2: SUITE 204 CITY: BEND STATE: OR ZIP: 97703 FORMER NAME: FORMER CONFORMED NAME: STONEPINE CAPITAL L P DATE OF NAME CHANGE: 20060724 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIASMA, INC CENTRAL INDEX KEY: 0001339469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 140 KENDRICK STREET STREET 2: BUILDING C EAST CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 617-928-5300 MAIL ADDRESS: STREET 1: 140 KENDRICK STREET STREET 2: BUILDING C EAST CITY: NEEDHAM STATE: MA ZIP: 02494 FORMER COMPANY: FORMER CONFORMED NAME: CHIASMA INC DATE OF NAME CHANGE: 20050922 4 1 doc1.xml FORM 4 X0306 4 2021-08-05 1 0001339469 CHIASMA, INC CHMA 0001370042 STONEPINE CAPITAL, L.P. 919 NW BOND STREET, SUITE 204 BEND OR 97703 0 0 1 0 Common Stock 2021-08-05 4 D 0 6770000 D 0 I See Footnote The filers are Stonepine Capital Management, LLC ("Stonepine"), Stonepine Capital, L.P. (the Partnership"), Jon M. Plexico and Timothy P. Lynch. Stonepine is the general partner and investment adviser of the Partnership. Mr. Plexico and Mr. Lynch are Stonepine's managers and control persons. These securities are held directly by the Partnership for the benefit of its investors and are indirectly beneficially owned by Stonepine, as the general partner and investment adviser of the Partnership, and by Mr. Plexico and Mr. Lynch, as Stonepine's control persons. Stonepine is filing this Form 4 for itself and the other filers. The filers are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. Each filer disclaims beneficial ownership of these securities except to the extent of that filer's pecuniary interest therein. This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement") dated as of May 4, 2021, by and among Chiasma, Inc. (the "Company), Amryt Pharma plc ("Parent"), and Acorn Merger Sub, Inc., an indirect wholly-owned subsidiary of Parent ("Merger Sub") pursuant to which Merger Sub merged with and into the Company (the "Merger") with the Company surviving as an indirect wholly owned subsidiary of Parent effective as of August 5, 2021 (the "Effective Time"). At the Effective Time, each share of common stock of the Company (each, a "Share") (excluding any Shares held in the treasury of the Company or owned, directly or indirectly, by Parent or Merger Sub immediately prior to the Effective Time) was cancelled and converted into the right to receive 0.396 American Depositary Shares of Parent representing five ordinary shares of Parent. Stonepine Capital, L.P., by Timothy P. Lynch, Manager of its General Partner 2021-08-09